AGP Executive Report
Last update: 10 hours agoCancer Care Update: In the FLAIR phase 3 trial, continuous ibrutinib plus rituximab preserved health-related quality of life versus FCR in previously untreated CLL, with overall EQ-5D scores essentially unchanged over 48 months, while some functioning measures favoured the ibrutinib/rituximab arm. Disability Benefits: The DWP has launched a 10-day consultation on major PIP changes affecting 3.9 million claimants, including how reviews work and whether the department can seek medical info directly from the NHS. Infectious Disease Watch: WHO has declared the Congo Ebola outbreak a public health emergency of international concern, with nearly 500 suspected cases and 116 deaths reported, and an American case being sent to Germany for treatment. NHS Data Reform: The King’s Speech backs a single patient record for health and social care, aiming for pilots from 2028 and wider rollout after. Women’s Health Litigation: Reports highlight ongoing Depo-Provera legal action in Scotland after claims of serious brain tumour outcomes.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
